SK bioscience, a pharmaceutical affiliate under South Korea's SK Group, said Friday its typhoid conjugate vaccine has obtained prequalification certification from the World Health Organization. The vaccine, named SKYTyphoid, was jointly developed by the South Korean company and the International Vaccine Institute, with financial support from the Bill & Melinda Gates Foundation, according to SK bioscience. SK...